Tuesday, 06. January 2009

Life sciences


Advanced genomics and its applications for health



Combating major diseases



Applications-orientated genomic approaches to medical knowledge and technologies



Combating cardiovascular diseases, diabetes, and rare diseases



Combating resistance to antibiotics and other drugs



Studying the brain and combating diseases of the nervous system



Studying human development and the ageing process



Combating cancer



Confronting the major communicable diseases linked to poverty



Specific support actions across thematic priority 1


Policy support

International co-operation

Reporting module


COBRA - Combating resistance to antibiotics by broadening the knowledge on molecular mechanisms behind resistance to inhibitor of cell wall synthesis (Life sciences, genomics and biotechnology for health) (2004-02-01 - 2007-04-30) (»add to infobox)



ACRONYM:COBRA
BUDGET:7.932.000 €
FUNDING:2.985.000 €
INSTRUMENT:Specific Targeted Research Project
PROGRAMME:Life sciences, genomics and biotechnology for health
This STREP aims at the elucidation of the molecular mechanisms of resistance to inhibitors of cell wall synthesis in bacteria responsible for severe nosocomial and community-acquired infections. It is focused on ß-lactams, the major class of antibiotics in current clinical use, and on resistance due to modification of the cell wall synthesizing machinery and to production of ß- lactamases, the most prevalent mechanisms in Gram-positive and Gram-negative bacteria, respectively. The specific aims concerning S. pneumoniae, S. aureus, and Enterococcus are (i) to elucidate the 3D structures and structure/activity relationships of the transpeptidase domains of the penicillin- binding proteins (PBPs), and (ii) to understand the role of non-PBP factors critical for resistance, including the glycosyltransferases, that cooperate with the transpeptidases for peptidoglycan polymerisation, the tRNA-dependent ligases, that synthesize the precursor side chain specifically required for the transpeptidase activity of low-affinity PBPs, and recently discovered regulatory factors. These studies will form a reference to globally assess the modifications of the structure, function, and dynamics of the peptidoglycan assembly pathways responsible for emergence of resistance. Concerning Pseudomonas, Acinetobacter, and the Enterobacteriaceae, the specific aims are (i) to identify new ß-lactamases and determine their 3D structures, (ii) to elucidate the regulation of ß- lactamase gene expression and the mechanisms responsible for their mobility, and (iii) to establish the relative contribution of ß-lactamases, membrane impermeability, and drug efflux to resistance. The knowledge of all aspects of resistance gained during the STREP will be essential to understand the consequences of antibiotic use on the dissemination and modification of resistance genes, and, more immediately, to develop novel diagnostic tools, based on the identification of speci#

Keywords:
Antibiotic resistance; -lactams; regulation of expression; gene mobility; targets; crystallography

COORDINATOR (1/1) 


Laurent GUTMANN (Contact / INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR101 - Paris) (FR - France))

PARTICIPANTS (14/14) 


Jean-Marie FRERE (Contact / UNIVERSITE DE LIEGE (BE332 - Arr. Liège) (BE - Belgium))

Tanneke DEN BLAAUWEN (Contact / UNIVERSITEIT VAN AMSTERDAM (NL326 - Groot-Amsterdam) (NL - Netherlands))

Regine HAKENBECK (Contact / TECHNISCHE UNIVERSITAET KAISERSLAUTERN (DEB32 - Kaiserslautern, Kreisfreie Stadt) (DE - Germany))

Brigitte BERGER-BÄCHI (Contact / UNIVERSITAET ZUERICH (CH04 - Zürich) (CH - Switzerland))

Juan A. AYALA (Contact / CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (ES300 - Madrid) (ES - Spain))

Dominique MENGIN-LECREULX (Contact / UNIVERSITE PARIS-SUD (FR104 - Essonne) (FR - France))

Tim BUGG (Contact / THE UNIVERSITY OF WARWICK (UKG33 - Coventry) (UK - Great Britain))

Thierry VERNET (Contact / CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR101 - Paris) (FR - France))

Rafael CANTON (Contact / HOSPITAL UNIVERSITARIO RAMON Y CAJAL (ES300 - Madrid) (ES - Spain))

David LIVERMORE (Contact / HEALTH PROTECTION AGENCY (UKI11 - Inner London - West) (UK - Great Britain))

Marek GNIADKOWSKI (Contact / NARODOWY INSTYTUT LEKOW (PL127 - Miasto Warszawa) (PL - Poland))

Timothy WALSH (Contact / UNIVERSITY OF BRISTOL (UKK11 - Bristol, City of) (UK - Great Britain))

Gian Maria ROSSOLINI (Contact / UNIVERSITA DEGLI STUDI DI SIENA (ITE19 - Siena) (IT - Italy))

Jonathan DANDO (Contact / INSERM - TRANSFERT SA (FR101 - Paris) (FR - France))

RELATED THEMATIC AREAS (1/1) 

Combating resistance to antibiotics and other drugs




SEARCH



»Advanced Search



SHORT CUTS

»Thematic areas

»Organisations

»Persons



INFOBOX (0/0) show all
Your infobox is empty


LifeCompetence is operated by AVEDAS.
LifeCompetence operated by AVEDAS
Contact: support@avedas.com


Powered by CONVERIS 2.0